Melissa Parra is driven by a passion for cross-functional execution and innovation, making her an ideal fit for her role as Vice President of Operations, PMO & Continuous Improvement at Ambry Genetics. In this position, Melissa leads the Continuous Improvement Office and Scaled Agile Delivery Group, transforming how Ambry delivers innovation. Since joining Ambry in 2010, she has led cross-functional teams through major milestones, including overseeing many of Ambry’s major product launches such as  the launching the first NextGen sequencing platform, the first Clinical exome product on the market, the first Cancer NGS platforms on the market, and the RNAInsight launches.  She was integral in establishing much of the functionality and system infrastructure within Ambry, including the foundational design of Ambry’s variant analysis software AVA. Melissa holds a BS in Molecular Genetics from UC Davis and an MS in Genetic Counseling from California State University, Northridge.